| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Reproductive Biology, Department of Gynecology and Obstetrics, Stanford University School of Medicine, Stanford, California 94305-5317 USA
| Abstract |
|---|
|
|
|---|
| I. Life History of Ovarian Follicles |
|---|
|
|
|---|
|
|
In contrast, cyclic recruitment starts after pubertal onset and is the result of the increase in circulating FSH during each reproductive cycle that rescues a cohort of antral follicles from atresia. In rodents, the recruitable early antral follicles are 0.20.4 mm in diameter, whereas human follicles at the comparable stage are larger (25 mm in diameter) and have acquired antrum for some time. During cyclic recruitment, only a limited number of follicles survive, and the default pathway is to undergo atresia. Oocytes in these follicles have already completed their growth, acquired a zona pellucida, and are competent to resume meiosis (11 12 ).
C. Negative and positive selection leading to dominance
Similar to the confusion associated with two distinct stages of
follicle recruitment, the FSH-initiated cyclic recruitment step is
sometimes described interchangeably with the process of follicle
selection (9 10 13 ). Cyclic recruitment and selection of follicles
represent a continuous process, eventually leading to the emergence of
the preovulatory follicle(s). Cyclic recruitment and final follicle
selection are most clearly illustrated during the human menstrual cycle
(Fig. 2
). After increases in circulating
FSH during the perimenstrual period, a cohort of antral follicles
escapes apoptosis due to the survival action of FSH. Among this group
of about 10 antral follicles (found in young adults), one of the
leading follicles grows faster than the rest of the cohort and produces
higher levels of estrogens and inhibins (4 ). Although the exact reasons
why one follicle emerges as dominant are unclear, this follicle is
likely to be more sensitive to FSH (6 ), perhaps because of enhanced FSH
and/or LH receptor expression or increases in local growth factors that
augment FSH responsiveness as suggested by bovine studies (14 15 16 ).
Estrogens and inhibins produced by the largest follicle suppress
pituitary FSH released during the midfollicular phase. As a result, the
remaining growing antral follicles are deprived of adequate FSH
stimulation required for survival (17 ). In monkeys, it has been
elegantly demonstrated that immunoneutralization of the actions of
circulating estrogens during the midfollicular phase leads to sustained
elevation of circulating FSH, thus allowing the development of multiple
preovulatory follicles (18 ). Furthermore, administration of exogenous
estrogens suppresses follicle development in women (19 20 ), whereas
treatment with high levels of exogenous gonadotropins during ovulation
induction in women is widely known to stimulate the growth of multiple
preovulatory follicles (6 ).
|
Cyclic recruitment of early antral follicles and selection of dominant follicles in rodents is similar to that of the primates with the major exception that multiple follicles become dominant during each estrous cycle. Monoovulatory and polyovulatory species likely differ in the threshold (or set point) for negative feedback signals, presumably a genetically determined trait (27 28 ). The law of follicular constancy proposed by Lipschutz (29 ) emphasizes that the ovulatory number remains constant in a given species even when a single ovary or a large portion of the remaining ovary is removed. Thus, findings of compensatory ovulation (30 ) underline the importance of the putative central set point within a given species. In several high fecundity strains of sheep, the follicular negative feedback signals (estrogens and inhibins) secreted by each individual follicle are decreased, thus allowing the selection of more preovulatory follicles (31 ). In general, the preovulatory dominant follicles in these animals are of a smaller size than those found in the low fecundity strain (32 33 34 ). Furthermore, species and strain differences in follicular responsiveness to FSH (35 ), or the available number of growing antral follicles, may also play a role in determining the number of preovulatory-size follicles.
D. Chronicle of early follicle development in humans
In humans, primordial germ cells arrive in the gonadal ridge
from the yolk sac endoderm by the seventh week of gestation to become
oogonia, which proliferate by mitosis before differentiating into
primary oocytes. Some oogonia begin transformation into primary oocytes
and enter the first stages of meiosis at around 1112 weeks of
gestation (Fig. 3
). The total germ cell
number peaks at 20 weeks. After this time, the rate of oogonial
division declines. Primordial follicle formation begins around
midgestation when a single layer of pregranulosa cells surround each
oocyte and continues until just after birth (36 ). After oocytes are
within the primordial follicles, they remain arrested in the
dictyate stage of meiosis I. From a peak of 6 to 7 million at 20
weeks of gestation, the oocyte number falls dramatically so that at
birth, there are only 300,000 to 400,000 remaining (37 38 ). Oocytes
not surrounded by granulosa cells to form primordial follicles are
lost, probably via apoptosis (39 40 41 ). Meanwhile, some primordial
follicles leave the resting pool by initiating growth (Fig. 2
; initial
recruitment). Once entering the growing pool, most growing follicles
progress to the antral stage, at which point they inevitably undergo
atresia. After pubertal onset, a small number of the antral follicles
can be rescued by gonadotropins to continue growth (Fig. 2
; cyclic
recruitment), and normally one Graafian follicle is formed each month
in preparation for ovulation. Antral follicles (25 mm in diameter)
develop into Graafian follicles in only 14 days during the follicular
phase of the menstrual cycle, although more than 85 days are needed for
late secondary follicles to grow into preovulatory follicles (1 ) (Fig. 2
). In addition, it has been estimated that more than 120 days are
needed for primary follicles to grow into the secondary stage and even
longer for the development of primordial follicles into primary
follicles (1 42 ). Thus, the entire growth phase of a follicle is much
greater than 220 days or eight menstrual cycles.
|
E. Chronicle of early follicle development in rodents
Important landmarks of ovarian development in rats are similar to
those in the human; however, the timing is greatly compressed.
Primordial germ cells migrate to the gonadal ridge late in embryonic
development to become oogonia. At birth, the rat ovary consists of
cords and oogonia (Fig. 3
). Primordial follicles are formed by day 3 of
age, and the first wave of follicles develops into antral follicles
over the next 3 weeks (49 50 51 52 53 ). Well developed secondary follicles are
found by day 7 of age. Minimal ovarian cell apoptosis can be found
until day 18 when early antral follicles are apparent (54 55 ). Puberty
or first estrus occurs around day 34. The regular estrous cycles
continue until around 1012 months of age when the cycles become
prolonged and irregular (56 57 ). By age 1215 months, animals enter
persistent estrus, and this is followed by persistent diestrus and
ultimately anestrus (58 59 ).
The timing of follicle growth has been meticulously evaluated in adult
rats (2 ). The follicle grows from about 25 µm in diameter (primordial
follicles) to 500800 µm in diameter (preovulatory follicles) over a
period of greater than 60 days (or about 15 estrous cycles) (Fig. 2
).
The time for primordial follicles to grow to the secondary follicle
stage may be more than 30 days or comparable to the time (28 plus 23
days) to grow from the secondary stage to ovulation. Thus, as in the
human, early follicle growth in rodents is very protracted. Of
interest, the rate of development of the first wave of follicles in
juvenile rats (Fig. 3
) is more rapid than that in adult cycling animals
(60 ) (Fig. 2
).
| II. Initial Recruitment of Follicles and Regulation of Early Follicle Growth |
|---|
|
|
|---|
By counting follicles of different categories in ovarian sections, rates of follicle progression and loss have been estimated (1 2 5 45 61 62 63 ). Despite the limitations of this approach, several useful models have been formulated to describe the dynamics of initial recruitment of follicles. Although a radioactive decay model proposed a constant loss of a fixed number of resting follicles from the original pool over time (61 64 ), some studies suggested a decreasing number of follicles initiate growth as the ovary ages, in proportion to the number of remaining follicles in the diminishing supply (65 ). Morphometric studies further suggested that follicles initiate growth based upon the order in which they were formed (2 ).
The decay model proposed to account for the baseline rate of the initial recruitment of follicles has been further modified based on observed variations in the rate of follicle loss from the resting pool over the reproductive life span. An accelerated loss of follicles from the resting pool has been found during the initial waves of follicle growth in infantile rodents (66 ). In addition, morphometric studies have demonstrated that an increasing percentage of follicles is lost in the perimenopausal years in humans (44 46 ). In both of these situations, serum gonadotropins are elevated compared with those during the peak reproductive years. The accelerated rate of loss of follicles in infantile rodents has been attributed both to a lack of mature follicles that might exert a negative effect on initial recruitment and to qualitative differences in the first groups of growing follicles (5 61 ). Likewise, the accelerated follicle loss in perimenopausal women may reflect intrinsic differences in their remaining follicles. Although the observed follicle depletion may be due to increasing serum gonadotropin levels, changes in gonadotropin secretion could also be the result of diminishing inhibitory influences from a lower number of growing follicles.
B. Role of gonadotropins, intraovarian factors, and the oocyte in
primary follicle growth
Resting follicles are likely to be under constant inhibitory
influences of systemic and/or local origins to remain dormant (67 ). A
decrease of inhibitory influences and/or an increase of stimulatory
factors allow the initiation of follicle growth. In hypophysectomized
rodents, decreased initial recruitment of follicles is evidenced by a
larger resting pool as compared with nonoperated controls (61 68 ).
Elevated serum FSH levels are associated with accelerated initial
recruitment found in both the early and late stages of reproductive
life, as mentioned earlier. High tonic LH/human CG (hCG) levels may
also reduce the number of resting follicles. In transgenic mice
overexpressing a long-acting LH, primordial follicles are lost from the
resting pool more rapidly than controls (69 ). However, FSH and LH are
unlikely to exert direct actions on primordial follicles because
functional gonadotropin receptors have not yet developed in them
(70 71 72 73 74 ). Instead, the ability of FSH to accelerate the development of
preantral follicles, as described in the following section, may
indirectly increase the loss of resting follicles from the dormant
pool. Other factors, such as elevated steroid levels and mediation by
paracrine factors, may also have a role in the loss of follicles from
the transgenic animals.
Although follicles do not have functional FSH receptors until the secondary stage, pregranulosa cells and primordial follicles respond to activators of the cAMP pathways (e.g., forskolin and cAMP analogs) with increased expression of aromatase and FSH receptors (75 ). It has been proposed that endogenous activators of cAMP may play a role in the differentiation of follicles after their initial recruitment (76 ). Treatment of ovarian explants from neonatal rats with vasoactive intestinal peptide or norepinephrine increases cAMP production and accelerates early follicle development. Because the first follicles that grow in the rat ovary are in the highly innervated corticomedullary junction, the first wave of follicle growth may be facilitated by these local neurotransmitters.
The role of the oocyte in the initial recruitment of follicles has been considered. During development, granulosa cells of primordial follicles start to divide (49 ), followed by morphological changes to the cuboidal shape characteristic of primary follicles. Because an increase in oocyte size is not evident until formation of the primary follicle, a passive role of the oocyte in initial recruitment has been suggested (12 ). Based on the observation that the number of chiasmata, or crossing-over events, in ovulated oocytes decreases with the increasing age of an animal, it was proposed that the order of follicle recruitment is related to the order in which the oocytes entered meiosis during development (61 ). This "production line" hypothesis predicts that the first oocytes entering meiosis are the first ones maturing and ovulating. In addition, Hirshfield (2 ) has demonstrated that rapidly progressing oocytes located near the corticomedullary junction of the ovary begin growth earlier and are enclosed into follicles that initiate growth during the neonatal and infantile period, a time of accelerated follicle loss. In contrast, oocytes that undergo slower meiotic progression are located closer to the cortex and are enclosed in follicles that grow later in life. Meiotic competence of human follicles declines with age (77 ), and this finding has been used in support of the production line hypothesis. However, the reduction of oocyte quality could be due to poorer conditions present during folliculogenesis after age 35. These issues have yet to be resolved.
Factors involved in oocyte-granulosa cell communication in early
follicles have also been proposed to have a role in initial
recruitment. The Steel factor or kit ligand is expressed by granulosa
cells of growing follicles whereas c-kit, a tyrosine kinase receptor of
the platelet-derived growth factor receptor family, is located
on oocytes and theca cells. Mutations in mice that prevent the
production of the soluble form of the kit ligand lead to failure of
follicular growth beyond the primary stage (78 79 80 ) (Table 2
). Less severe mutations that result in
reduced production of the soluble ligand allow a few follicles to grow
to the antral stage. These animals ovulate sporadically and show
limited fertility. Of interest, treatment of neonatal mice with a
neutralizing antibody against the c-kit receptor caused apparent
disturbances in initial follicle recruitment, primary follicle growth,
and antrum formation in larger follicles (81 ). Mutations affecting the
function of c-kit in humans, however, do not seem to affect female
fertility (82 ). The role of c-kit in human ovarian function requires
further study.
|
production by neonatal ovarian explants in rats
as well as the growth and differentiation of cultured preantral rat
follicles (84 ). However, GDF-9 production is not obligatory for inhibin
production because inhibin-
transcript continues to be found in
GDF-9 null mice (89 ). Based on its sequence homolog to GDF-9 and other
TGF-ß family proteins, a novel gene, GDF-9B (90 ), also named as
BMP-15 (91 ), has recently been identified. Of interest, the expression
of the GDF-9B/BMP-15 transcript, as in that for GDF-9, is restricted to
the oocyte. It is possible that multiple paracrine factors are involved
in the communication between oocyte and somatic cells during early
follicle development. Although these studies provide insight into the growth process of very early follicles, the exact mechanisms propelling the primordial follicles to leave the resting pool remain elusive. Of importance, both kit ligand and GDF-9 are first found in primary follicles and their role in primordial follicle activation remains to be established. Further studies are needed to reveal potential inhibitory factors and/or intraovarian-stimulating factors that are involved in the initial stage of follicle recruitment. Recent establishment of a serum-free culture of baboon primordial follicles capable of initiating growth in vitro (92 ) could provide further insight into the mechanisms of initial follicle recruitment.
C. Preantral follicle growth and differentiation
Compared with the initial recruitment process, substantially more
is known about the regulation of subsequent follicle differentiation
and growth. After initial recruitment, granulosa cells in primary
follicles undergo profound changes, progressively acquiring the
differentiated characteristics of epithelial cells found in secondary
follicles. The oocyte continues to grow, the zona pellucida is formed,
theca condenses around the preantral follicle, and the vascular supply
develops.
In vitro studies have shown that granulosa-oocyte
communication is essential for normal oocyte growth in early follicles.
Immature oocytes separated from granulosa cells do not grow, but
oocytes allowed to maintain gap junctions with granulosa cells grow at
a near-normal rate (12 ). In mice, a gap junction protein, connexin 37,
is expressed at the oocyte-granulosa cell junction by the time
follicles have developed to the secondary stage, whereas follicles of
mice that lack connexin 37 do not progress normally (93 ) (Table 2
).
These defective follicles contain normal zona pellucida and granulosa
cell processes but lack oocyte-granulosa gap junctions and have
impaired oocyte-granulosa communication. They progress normally to the
late secondary stage and form a limited number of small antral
follicles. The oocytes do not reach full size and are not competent to
undergo meiosis. Several studies have further demonstrated that oocytes
secrete factors to regulate granulosa cell functions (94 ), including
granulosa cell division (95 ), LH receptor formation (96 ), and
steroidogenesis (97 98 ) as well as cumulus cell expansion (85 ). These
studies underscore the concept that granulosa-oocyte communication is
important for normal preantral follicle development.
Because preantral follicle development proceeds much slower than that
of larger antral follicles, it is possible that ovarian growth and
differentiation genes are suppressed during early follicle development.
High levels of the Wilms tumor gene, WT1, are expressed in the
granulosa cells of primary follicles in rats with lower levels in
secondary follicles and negligible levels in antral and preovulatory
follicles (99 ). Recent studies extend the finding of restricted WT1
expression in immature follicles to diverse avian (chicken) and
mammalian (porcine and monkey) species and over the reproductive life
span in rats (100 ). WT1, a transcription factor with zinc finger
domains (101 ), suppresses the expression of several growth factors and
their receptors in different cell types. Furthermore, in
vitro studies demonstrated that WT1 represses activities of the
promoters for inhibin-
and FSH receptor, marker genes essential for
follicle development. In gel retardation assays, recombinant WT1
proteins interact directly with consensus DNA sequences in the
inhibin-
gene promoter (100 ). Thus, WT1 may act as a stasis factor
on smaller follicles, and falling levels of WT1 allow the progression
of early follicle development. Mutant mice with deletion of the WT1
gene die during embryonic development, thus preventing analysis of
ovarian follicle development. In human males with inactivating
mutations of WT1, gonadal dysgenesis is prominent (102 ); but detailed
analysis of ovarian phenotypes in human females with WT1 mutations
(103 ) remains to be performed. Further studies are needed to elucidate
the regulation of WT1 expression in human follicles as well as the
interaction of WT1 with other genes involved in follicle development.
Granulosa-theca cell interactions may also have a role in the development of early follicles. Although the role of sex steroids in preantral follicle development is still unclear, a recent study suggested that androgen treatment in intact monkeys increases the number of preantral and small antral follicles up to 1 mm in diameter through androgen receptors (104 105 106 ). In cultured mouse preantral follicles, androgen treatment also augments follicle growth (107 ).
Rat preantral follicles have been shown to secrete proteins that enhance the growth and differentiation of theca cells before their expression of LH receptors (51 ). Likewise, cocultures of theca and granulosa cells enhance proliferation and steroidogenesis of both cell types (108 ). The observed interactions between granulosa and theca cells are probably mediated by paracrine growth factors. Recent studies indicated that keratinocyte growth factor, or fibroblast growth factor-7, a paracrine hormone secreted by theca cells (109 ), enhances the growth of preantral rat follicles in culture (110 ).
Treatment of dissociated ovarian cells from juvenile rats with activin and FSH enhances formation and growth of follicular structure (111 ). Activin treatment also enhances FSH-stimulated inhibin production in dispersed ovarian cells from neonatal rats (112 ). In mice, cultured preantral follicles secrete activin, and treatment with recombinant activin enhances FSH-stimulated inhibin and estrogen production (113 ). Furthermore, studies using cocultures of mouse follicles at different stages of development suggested that activin secreted from secondary follicles causes small preantral follicles to remain dormant (114 115 ). The exact stage-dependent effects of activin in early follicle development remain to be elucidated.
High levels of IGF-I and IGF receptors have been found in postnatal rats during preantral follicle development (116 ). However, follicles seem to develop relatively normally to the early antral stage in mutant mice lacking IGF-I, although numerical morphometrics were not performed (117 ). Studies using these mutant mice further suggested that ovarian IGF-I expression serves to enhance granulosa cell FSH responsiveness by augmenting FSH receptor expression (118 ). A large body of data exists on the effects of growth factors on monolayer cultures of granulosa and theca-interstitial cells as well as on cultures of antral and preovulatory follicles (5 24 119 120 ). It is clear that paracrine growth factors are also involved in preantral follicle development. With recent advances in transgenic technology, more than 30 mouse models with ovarian defects at different stages of follicle development have been described (reviewed in Ref. 121 ). Derivation of additional mutant mice with ovarian phenotypes will further enhance our understanding of early follicle development.
D. Preantral follicles are gonadotropin responsive
Several recent studies investigated the role of FSH on follicle
development based on mutant mice with a defective FSH-ß or FSH
receptor gene (122 123 ) and in patients with loss-of-function FSH
receptors (124 ). Although the growth of preantral follicles has been
considered to be gonadotropin independent because follicles can develop
to the antral stage in animals or humans with minimal circulating FSH
or defective FSH receptors (6 122 124 125 126 127 ), studies in rodents have
suggested that the development of early follicles is under the
influence of gonadotropins. During the first 3 weeks of life in rats,
the first wave of follicles begins to grow, corresponding to events
found during fetal life in the human ovary (Fig. 3
). Functional FSH and
LH receptors are present when well developed secondary follicles are
found by day 7 of age. In addition, serum FSH levels are elevated
between days 11 and 19, a time of rapid follicle growth (128 129 130 ).
Treatment with dihydrotestosterone propionate during the first week of
life decreases serum gonadotropins and leads to a delay in ovarian FSH
receptor acquisition (131 ). Conversely, treatment of infantile rats
with PMSG increases ovarian weight (132 ), whereas treatment of neonatal
rats with a GnRH antagonist reduces the number of growing ovarian
follicles found at puberty (7 ).
Taking advantage of the relatively uniform development of the first wave of follicles in the postnatal rat ovary, the role of endogenous and exogenous gonadotropins on preantral follicle development was evaluated (50 ). Reduction of the high levels of gonadotropins present in juvenile rats by either hypophysectomy or GnRH antagonist treatment decreases ovarian weight at day 19 of age and reduces the number of developing follicles together with increasing atresia of the remaining ones. In contrast, treatment with FSH in intact, hypophysectomized, or GnRH antagonist-treated juvenile rats increases ovarian weight and preantral follicle development (50 ). In vitro studies on the role of FSH in preantral follicle development have been conflicting. In one model, FSH treatment promotes the progression of cultured rat follicles to the antral stage (133 ). In another study, FSH treatment alone does not enhance granulosa cell division or steroidogenesis (111 ). In mice, FSH treatment enhances antral formation without increasing granulosa cell numbers in cultured follicles (134 ) whereas, in cultured hamster follicles, FSH treatment increases granulosa cell division (135 ). Using a cGMP analog to suppress apoptosis in preantral rat follicles in serum-free cultures, it was demonstrated that FSH treatment increases both follicle size and cell number (54 ).
Recently, FSH has been shown to stimulate the expression of cyclin D2,
a cell cycle protein important in the G1 phase of
cell division. Mice lacking cyclin D2 are infertile, and granulosa cell
replication is impaired as early as the secondary follicle stage (136 )
(Table 2
). The paucity of granulosa cells results in the formation of
small atypical antral follicles that cannot ovulate properly.
Thus, these results demonstrate that preantral follicles respond to
gonadotropins with cell division and differentiation. However, as
discussed earlier, follicles can progress to the antral stage in the
absence of gonadotropins. In hypogonadal mice (127 ) or
hypophysectomized rats (137 ), ovarian follicles can develop to the
secondary and early antral stages, but more slowly and in fewer
numbers. In individuals with hypogonadotropic hypogonadism, treatment
with exogenous gonadotropins leads to the development of preovulatory
follicles within 2 weeks, suggesting that antral follicles are present
and available for cyclic recruitment (138 ). Clearly, continued
development of antral and larger follicles is dependent on the presence
of FSH, but gonadotropin responsiveness may occur earlier in follicle
development (139 ) than is widely believed (Fig. 4
). This concept is further supported by
studies on human early follicles in ovarian xenografts transplanted
into the kidney capsule of immunodeficient and hypogonadal mice (140 ).
In this model, FSH was shown to be required for the growth of follicles
beyond the two-layer granulosa cell stage. Therefore, gonadotropin
fluctuations during the estrous cycle in the rodent may not only
advance the development of antral follicles but may also affect smaller
growing follicles that are several cycles away from becoming the
leading cohort. In humans, exogenous gonadotropins could have an effect
on follicle development for several months after a controlled ovarian
hyperstimulation cycle, although the exact role of gonadotropins
remains to be elucidated.
|
| III. Cyclic Recruitment Of Follicles to Escape from Atresia |
|---|
|
|
|---|
FSH and LH are important trophic factors for the proliferation and survival of follicular somatic cells and the cyclic recruitment of antral follicles. Suppression of serum gonadotropins after hypophysectomy leads to atresia and apoptosis of developing follicles (147 ), whereas FSH treatment of cultured early antral follicles prevents the spontaneous onset of follicular apoptosis (148 ). However, LH/hCG treatment alone is ineffective, suggesting that FSH is the predominant survival factor at this stage of follicle development (148 ). In rats, estrogens are potent antiapoptotic hormones in early antral follicles (149 ), although the role of estrogen in human follicles is still unclear. Follicular estrogen production is dependent upon both FSH stimulation of aromatase in the granulosa cells and LH stimulation of androstenedione production by the theca (24 ). Therefore, both gonadotropins play a role in the continued survival of growing follicles, but the cellular mechanism by which FSH or estrogen ensures the survival of early antral follicles is unknown.
B. Intrafollicular hormonal mechanisms to ensure survival of
preovulatory follicles
It is becoming evident that survival factors are needed to sustain
folliculogenesis during the progression of follicle development (Fig. 4
). Recent rodent studies indicate that preantral follicles in
serum-free cultures undergo apoptosis despite exposure to gonadotropins
or cAMP analogs (54 ), suggesting that gonadotropins are probably not
survival factors at early stages of folliculogenesis. As discussed
above, FSH seems to be the most important survival factor for early
antral follicles. However, in preovulatory follicles, numerous factors
promote follicle cell survival (142 150 151 152 ), indicating that
overlapping hormonal cascades are involved in maintaining follicles
that develop to this stage. The differential responsiveness of
follicles to hormonal signals at different developmental stages may
ensure a staggered supply of maturing follicles during reproductive
life.
An elaborate intrafollicular control mechanism ensures the survival of
preovulatory follicles (153 ). The onset of apoptosis in preovulatory
follicles in a serum-free culture is prevented by treatment with FSH
and LH (150 ). In addition, treatment with GH (151 ) or local factors
including IGF-I, epidermal growth factor, TGF
, and fibroblast growth
factor-2, likewise suppresses follicle cell apoptosis (150 154 ).
Interleukin-1ß is also a survival factor for preovulatory follicles,
and the action of interleukin-1ß is mediated through increases in the
production of nitric oxide, which, in turn, activates soluble guanyl
cyclase (152 ). Although gonadotropins are the most important survival
factors for preovulatory follicles, this array of extracellular signals
acting through endocrine, paracrine, autocrine, or juxtacrine
mechanisms, ensures their survival for ovulation.
| IV. Dynamics of the Follicle Pool: Puzzles and Unanswered Questions |
|---|
|
|
|---|
A. Does early onset of menarche lead to a corresponding younger age
at menopause?
No. Despite a substantial decrease in the age of menarche in women
during the last century, a corresponding change of the menopausal age
has not been detected (48 ). As discussed, initial follicle recruitment
and follicle loss from the resting pool begins long before pubertal
onset. Changes in the age of menarche as the result of environmental,
nutritional, or pathophysiological factors (such as in women with
central precocious puberty) allow an earlier onset of cyclic follicle
recruitment but should not affect the timing of follicle pool
depletion.
B. Do women of reproductive age who have undergone unilateral
ovariectomy or chemotherapy have an earlier onset of menopause?
Yes, but it is dependent on the timing of the procedure.
Unilateral oophorectomy or chemotherapy, which reduces the pool of
resting follicles, shortens the reproductive life span. Although
removal of up to 95% of ovarian tissue in monkeys does not affect
subsequent reproductive cycles for up to 1 yr (155 ), the size of the
resting follicle pool is a major determinant of ovarian senescence.
Thus, unilateral oophorectomy can accelerate reproductive aging. If
unilateral oophorectomy is performed in the later part of the human
reproductive years when the resting pool is smaller, substantial
advancement in menopausal age occurs (45 46 ). However, when the same
procedure is performed early in life, the menopausal age is less
affected, suggesting that a compensatory mechanism in initial follicle
recruitment might allow a lower number of follicles to initiate growth
(156 ).
In rodent studies, removal of one ovary accelerates follicle loss in the remaining ovary (30 ), but halving the total follicle number only results in the loss of a quarter of expected cycles (157 ). Furthermore, unilateral oophorectomy increases the loss of remaining primordial follicles in middle-aged rats but not in young rats operated on at 30 days of age (158 ). Likewise, treatment with a chemotherapy agent, busulfan, decreases the resting follicle pool by more than 90% in rats and substantially accelerates follicle depletion (159 ). Conversely, mutant mice deficient in a proapoptotic gene, Bax, maintain a larger resting pool of follicles later into adult life (160 ).
In humans, exposure to alkylating agents is associated with premature ovarian failure (161 ), and the degree of ovarian dysfunction seems to be inversely related to the age of drug exposure (162 ). Some reports suggest that treatment with GnRH agonist protects against chemotherapy-induced ovarian damage, possibly by reducing the rate of primordial follicle attrition (163 164 ). However, recent studies do not show a protective effect of GnRH agonist treatment on radiation-induced follicular injury (165 ). Given the increased survival rates of patients from cancers of childhood and early adulthood, more studies on potential protective measures of the follicle pool are greatly needed.
C. Do women who have used steroidal contraceptives have delayed
menopause?
Probably no. Prolonged exposure to steroidal contraceptive pills
mainly affects the ovulatory surges of circulating gonadotropins during
the fertile period. Thus, ovulation is suppressed, but follicles
continue to grow to the antral stage (6 ). It would seem likely that
neither initial nor cyclic recruitment of follicles would be affected.
However, since the advent of the oral contraceptive pill in the 1950s,
the first generation of pill takers have reached menopause, and
epidemiological studies have suggested that menopausal age may be
slightly delayed (166 167 ). Further studies of subsequent generations
of pill takers are needed to rule out compounding variables in the
population of "pill pioneers" (167 ).
D. Do women with increased parity have delayed menopause?
Yes. Epidemiological studies indicate that women with increased
parity show a delay in menopausal onset (166 168 169 ). Prolonged
elevation of circulating progesterone during pregnancy may suppress
initial follicle recruitment, thus maintaining a larger follicle pool
size. Early studies in pregnant mice indicated that fewer follicles
start growth per unit time (170 ). Indeed, middle-aged rats treated with
progesterone implants or allowed to undergo multiple pregnancies show a
delay in reproductive aging (171 ). Furthermore, prolonged treatment of
young rats with a progesterone implant is associated with the
conservation of follicle reserve in aging animals (172 ). One is unable
to distinguish, however, between a direct action of progesterone on
resting follicles and an indirect effect of progesterone mediated by
changes in gonadotropin secretion. Additional pregnancy-related factors
may also override the facilitatory effect of hCG on follicle exhaustion
(69 ) and could result in the protection of the follicle pool. It would
be interesting to determine whether users of levenorgestrel implants or
injectable medroxyprogesterone acetate showed any change in menopausal
timing.
E. Do women with dizygotic twins have an earlier onset of
menopause?
Maybe not. The exact mechanism of dizygotic twining is still
uncertain, although increased numbers of large antral follicles have
been found in mothers of dizygotic twins during the follicular phase of
their cycle (173 ). Assuming the increases in preovulatory follicles
found in these individuals are due to elevated gonadotropins during the
early follicular phase of their menstrual cycle (174 175 176 ), this
condition is likely due to enhanced cyclic recruitment of follicles and
should not alter initial recruitment and menopausal age. However, some
epidemiological studies have suggested that mothers of twins have an
earlier menopause (177 178 ), although this may be related to other
variables such as cigarette smoking which was not evaluated. Also,
women who are carriers of the Fragile X syndrome show increased
incidence of dizygotic twinning and an earlier onset of menopause
(179 ). The relationship between the defective FMR-1 (Fragile X Mental
Retardation) protein found in these patients, twinning, and ovarian
senescence awaits further analysis.
F. Do women who have undergone repeated cycles of controlled
ovarian hyperstimulation with gonadotropins have an earlier onset of
menopause?
A qualified no because exogenous gonadotropins are believed to act
mainly on antral follicles to start cyclic recruitment. Although an
accelerated decrease of the follicle pool size before menopause is
associated with increases in circulating FSH, it is still unclear
whether the premenopausal increase in FSH is the result or the cause of
follicle pool depletion. There is no doubt that initial recruitment of
follicles can proceed without gonadotropins, but it is unclear whether
repeated exogenous gonadotropin treatment might accelerate follicle
loss by an indirect action mediated through gonadotropin-responsive
preantral follicles. Due to the possibility of underlying ovarian
disorders in women who undergo gonadotropin stimulation for
infertility, analysis of this issue may be difficult. Women who are egg
donors would be an interesting group to evaluate in this regard.
| V. Conclusions |
|---|
|
|
|---|
| Acknowledgments |
|---|
| Footnotes |
|---|
1 Supported by NIH Grant HD-31398, Specialized Cooperative Centers
Program in Reproduction Research, and K12-HD084908 cofunded by the
American Society for Reproductive Medicine through the Reproductive
Scientist Development Program. ![]()
2 Fellow of the Reproductive Scientist Development Program.
Present address: Department of Obstetrics and Gynecology, University of
Kentucky, Lexington, Kentucky 40536-0293 USA. ![]()
| References |
|---|
|
|
|---|
. Biol
Reprod 50:940948[Abstract]
gene promoter. Mol Endocrinol 9:13561366This article has been cited by other articles:
![]() |
N. Kobayashi, M. Orisaka, M. Cao, F. Kotsuji, A. Leader, N. Sakuragi, and B. K. Tsang Growth Differentiation Factor-9 Mediates Follicle-Stimulating Hormone-Thyroid Hormone Interaction in the Regulation of Rat Preantral Follicular Development Endocrinology, December 1, 2009; 150(12): 5566 - 5574. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Adhikari, G. Flohr, N. Gorre, Y. Shen, H. Yang, E. Lundin, Z. Lan, M. J. Gambello, and K. Liu Disruption of Tsc2 in oocytes leads to overactivation of the entire pool of primordial follicles Mol. Hum. Reprod., December 1, 2009; 15(12): 765 - 770. [Abstract] [Full Text] [PDF] |
||||
![]() |
The ESHRE Capri Workshop Group Female contraception over 40 Hum. Reprod. Update, November 1, 2009; 15(6): 599 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Edson, A. K. Nagaraja, and M. M. Matzuk The Mammalian Ovary from Genesis to Revelation Endocr. Rev., October 1, 2009; 30(6): 624 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gong and E. A. McGee Smad3 Is Required for Normal Follicular Follicle-Stimulating Hormone Responsiveness in the Mouse Biol Reprod, October 1, 2009; 81(4): 730 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Miao, K. Kikuchi, Q.-Y. Sun, and H. Schatten Oocyte aging: cellular and molecular changes, developmental potential and reversal possibility Hum. Reprod. Update, September 1, 2009; 15(5): 573 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. La Marca, F.J. Broekmans, A. Volpe, B.C. Fauser, N.S. Macklon, and on behalf of the ESHRE Special Interest Group for Anti-Mullerian hormone (AMH): what do we still need to know? Hum. Reprod., September 1, 2009; 24(9): 2264 - 2275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Xu, E. R. West-Farrell, R. L. Stouffer, L. D. Shea, T. K. Woodruff, and M. B. Zelinski Encapsulated Three-Dimensional Culture Supports Development of Nonhuman Primate Secondary Follicles Biol Reprod, September 1, 2009; 81(3): 587 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Adhikari and K. Liu Molecular Mechanisms Underlying the Activation of Mammalian Primordial Follicles Endocr. Rev., August 1, 2009; 30(5): 438 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Broekmans, M. R. Soules, and B. C. Fauser Ovarian Aging: Mechanisms and Clinical Consequences Endocr. Rev., August 1, 2009; 30(5): 465 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Reddy, D. Adhikari, W. Zheng, S. Liang, T. Hamalainen, V. Tohonen, W. Ogawa, T. Noda, S. Volarevic, I. Huhtaniemi, et al. PDK1 signaling in oocytes controls reproductive aging and lifespan by manipulating the survival of primordial follicles Hum. Mol. Genet., August 1, 2009; 18(15): 2813 - 2824. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Orisaka, J.-Y. Jiang, S. Orisaka, F. Kotsuji, and B. K. Tsang Growth Differentiation Factor 9 Promotes Rat Preantral Follicle Growth by Up-Regulating Follicular Androgen Biosynthesis Endocrinology, June 1, 2009; 150(6): 2740 - 2748. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Nicholas, S. L. Chavez, V. L. Baker, and R. A. Reijo Pera Instructing an Embryonic Stem Cell-Derived Oocyte Fate: Lessons from Endogenous Oogenesis Endocr. Rev., May 1, 2009; 30(3): 264 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H Ortega, N. R Salvetti, and V. Padmanabhan Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance Reproduction, May 1, 2009; 137(5): 865 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Trombly, T. K. Woodruff, and K. E. Mayo Suppression of Notch Signaling in the Neonatal Mouse Ovary Decreases Primordial Follicle Formation Endocrinology, February 1, 2009; 150(2): 1014 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.F.G. Verberg, M.J.C. Eijkemans, N.S. Macklon, E.M.E.W. Heijnen, E.B. Baart, F.P. Hohmann, B.C.J.M. Fauser, and F.J. Broekmans The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis Hum. Reprod. Update, January 1, 2009; 15(1): 5 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A McLaughlin and S. C McIver Awakening the oocyte: controlling primordial follicle development Reproduction, January 1, 2009; 137(1): 1 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.F.G. Verberg, N.S. Macklon, G. Nargund, R. Frydman, P. Devroey, F.J. Broekmans, and B.C.J.M. Fauser Mild ovarian stimulation for IVF Hum. Reprod. Update, January 1, 2009; 15(1): 13 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Martelli, N Bernabo, P Berardinelli, V Russo, C Rinaldi, O Di Giacinto, A Mauro, and B Barboni Vascular supply as a discriminating factor for pig preantral follicle selection Reproduction, January 1, 2009; 137(1): 45 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L Meistrich and G. Shetty Hormonal suppression for fertility preservation in males and females Reproduction, December 1, 2008; 136(6): 691 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-Y. Sun, K. Liu, and K. Kikuchi Oocyte-Specific Knockout: A Novel In Vivo Approach for Studying Gene Functions During Folliculogenesis, Oocyte Maturation, Fertilization, and Embryogenesis Biol Reprod, December 1, 2008; 79(6): 1014 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Buse, M. Zoller, and E. Van Esch The Macaque Ovary, with Special Reference to the Cynomolgus Macaque (Macaca fascicularis) Toxicol Pathol, December 1, 2008; 36(7_suppl): 24S - 66S. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jayaprakasan, B.K. Campbell, J.F. Hopkisson, J.S. Clewes, I.R. Johnson, and N.J. Raine-Fenning Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone Hum. Reprod., November 1, 2008; 23(11): 2577 - 2583. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Grigorova, M. Punab, K. Ausmees, and M. Laan FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men Hum. Reprod., September 1, 2008; 23(9): 2160 - 2166. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Viger, S. M. Guittot, M. Anttonen, D. B. Wilson, and M. Heikinheimo Role of the GATA Family of Transcription Factors in Endocrine Development, Function, and Disease Mol. Endocrinol., April 1, 2008; 22(4): 781 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Jones Meiosis in oocytes: predisposition to aneuploidy and its increased incidence with age Hum. Reprod. Update, March 1, 2008; 14(2): 143 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Reddy, L. Liu, D. Adhikari, K. Jagarlamudi, S. Rajareddy, Y. Shen, C. Du, W. Tang, T. Hamalainen, S. L. Peng, et al. Oocyte-Specific Deletion of Pten Causes Premature Activation of the Primordial Follicle Pool Science, February 1, 2008; 319(5863): 611 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J Spicer, P. Y Aad, D. T Allen, S. Mazerbourg, A. H Payne, and A. J Hsueh Growth Differentiation Factor 9 (GDF9) Stimulates Proliferation and Inhibits Steroidogenesis by Bovine Theca Cells: Influence of Follicle Size on Responses to GDF9 Biol Reprod, February 1, 2008; 78(2): 243 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.C.J.M. Fauser, K. Diedrich, P. Devroey, and on behalf of the Evian Annual Reproduction (EVAR) Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation Hum. Reprod. Update, January 1, 2008; 14(1): 1 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hoekstra, Z. Z. Zhao, C. B. Lambalk, G. Willemsen, N. G. Martin, D. I. Boomsma, and G. W. Montgomery Dizygotic twinning Hum. Reprod. Update, January 1, 2008; 14(1): 37 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Gallardo, G. B. John, K. Bradshaw, C. Welt, R. Reijo-Pera, P. H. Vogt, P. Touraine, S. Bione, D. Toniolo, L. M. Nelson, et al. Sequence variation at the human FOXO3 locus: a study of premature ovarian failure and primary amenorrhea Hum. Reprod., January 1, 2008; 23(1): 216 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rajareddy, P. Reddy, C. Du, L. Liu, K. Jagarlamudi, W. Tang, Y. Shen, C. Berthet, S. L. Peng, P. Kaldis, et al. p27kip1 (Cyclin-Dependent Kinase Inhibitor 1B) Controls Ovarian Development by Suppressing Follicle Endowment and Activation and Promoting Follicle Atresia in Mice Mol. Endocrinol., September 1, 2007; 21(9): 2189 - 2202. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. McTavish, M. Jimenez, K. A. Walters, J. Spaliviero, N. P. Groome, A. P. Themmen, J. A. Visser, D. J. Handelsman, and C. M. Allan Rising Follicle-Stimulating Hormone Levels with Age Accelerate Female Reproductive Failure Endocrinology, September 1, 2007; 148(9): 4432 - 4439. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sen, A. Bettegowda, F. Jimenez-Krassel, J. J. Ireland, and G. W. Smith Cocaine- and Amphetamine-Regulated Transcript Regulation of Follicle-Stimulating Hormone Signal Transduction in Bovine Granulosa Cells Endocrinology, September 1, 2007; 148(9): 4400 - 4410. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Kevenaar, A. P.N. Themmen, F. Rivadeneira, A. G. Uitterlinden, J. S.E. Laven, N. M. van Schoor, P. Lips, H. A.P. Pols, and J. A. Visser A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity Hum. Reprod., September 1, 2007; 22(9): 2382 - 2388. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Gallardo, G. B. John, L. Shirley, C. M. Contreras, E. A. Akbay, J. M. Haynie, S. E. Ward, M. J. Shidler, and D. H. Castrillon Genomewide Discovery and Classification of Candidate Ovarian Fertility Genes in the Mouse Genetics, September 1, 2007; 177(1): 179 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, J. Li, C. Ying Wang, A. H. Yan Kwok, and F. C. Leung Epidermal Growth Factor (EGF) Receptor Ligands in the Chicken Ovary: I. Evidence for Heparin-Binding EGF-Like Growth Factor (HB-EGF) as a Potential Oocyte-Derived Signal to Control Granulosa Cell Proliferation and HB-EGF and Kit Ligand Expression Endocrinology, July 1, 2007; 148(7): 3426 - 3440. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsepelidis, F. Devreker, I. Demeestere, A. Flahaut, Ch. Gervy, and Y. Englert Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women Hum. Reprod., July 1, 2007; 22(7): 1837 - 1840. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Kevenaar, A. P.N. Themmen, J. S.E. Laven, B. Sonntag, S. L. Fong, A. G. Uitterlinden, F. H. de Jong, H. A.P. Pols, M. Simoni, and J. A. Visser Anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women Hum. Reprod., June 1, 2007; 22(6): 1547 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B John, L. J Shirley, T. D Gallardo, and D. H Castrillon Specificity of the requirement for Foxo3 in primordial follicle activation Reproduction, May 1, 2007; 133(5): 855 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
P M. Lokman, K. A N George, S. L Divers, M. Algie, and G. Young 11-Ketotestosterone and IGF-I increase the size of previtellogenic oocytes from shortfinned eel, Anguilla australis, in vitro Reproduction, May 1, 2007; 133(5): 955 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Visser, A. L. L. Durlinger, I. J. J. Peters, E. R. van den Heuvel, U. M. Rose, P. Kramer, F. H. de Jong, and A. P. N. Themmen Increased Oocyte Degeneration and Follicular Atresia during the Estrous Cycle in Anti-Mullerian Hormone Null Mice Endocrinology, May 1, 2007; 148(5): 2301 - 2308. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Sleer and C. C. Taylor Cell-Type Localization of Platelet-Derived Growth Factors and Receptors in the Postnatal Rat Ovary and Follicle Biol Reprod, March 1, 2007; 76(3): 379 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Roberts, L. K. Arbogast, C. I. Friedman, D. E. Cohn, P. T. Kaumaya, and D. R. Danforth Neutralization of Endogenous Vascular Endothelial Growth Factor Depletes Primordial Follicles in the Mouse Ovary Biol Reprod, February 1, 2007; 76(2): 218 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, S. Rajareddy, P. Reddy, K. Jagarlamudi, C. Du, Y. Shen, Y. Guo, K. Boman, E. Lundin, U. Ottander, et al. Phosphorylation and inactivation of glycogen synthase kinase-3 by soluble kit ligand in mouse oocytes during early follicular development J. Mol. Endocrinol., January 1, 2007; 38(1): 137 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R Greenfeld, J. K Babus, P. A Furth, S. Marion, P. B Hoyer, and J. A Flaws BAX is involved in regulating follicular growth, but is dispensable for follicle atresia in adult mouse ovaries Reproduction, January 1, 2007; 133(1): 107 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, S. Rajareddy, P. Reddy, C. Du, K. Jagarlamudi, Y. Shen, D. Gunnarsson, G. Selstam, K. Boman, and K. Liu Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a Development, January 1, 2007; 134(1): 199 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Orisaka, K. Tajima, T. Mizutani, K. Miyamoto, B. K. Tsang, S. Fukuda, Y. Yoshida, and F. Kotsuji Granulosa Cells Promote Differentiation of Cortical Stromal Cells into Theca Cells in the Bovine Ovary Biol Reprod, November 1, 2006; 75(5): 734 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Orisaka, S. Orisaka, J.-Y. Jiang, J. Craig, Y. Wang, F. Kotsuji, and B. K. Tsang Growth Differentiation Factor 9 Is Antiapoptotic during Follicular Development from Preantral to Early Antral Stage Mol. Endocrinol., October 1, 2006; 20(10): 2456 - 2468. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Modi, D. Bhartiya, and C. Puri Developmental expression and cellular distribution of Mullerian inhibiting substance in the primate ovary. Reproduction, September 1, 2006; 132(3): 443 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.R. Barnett, C. Schilling, C.R. Greenfeld, D. Tomic, and J.A. Flaws Ovarian follicle development and transgenic mouse models Hum. Reprod. Update, September 1, 2006; 12(5): 537 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Campbell, J. Dickey, B. Beckman, G. Young, A. Pierce, H. Fukada, and P. Swanson Previtellogenic Oocyte Growth in Salmon: Relationships among Body Growth, Plasma Insulin-Like Growth Factor-1, Estradiol-17beta, Follicle-Stimulating Hormone and Expression of Ovarian Genes for Insulin-Like Growth Factors, Steroidogenic-Acute Regulatory Protein and Receptors for Gonadotropins, Growth Hormone, and Somatolactin Biol Reprod, July 1, 2006; 75(1): 34 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Del Borgo, R. A. Hughes, R. A. D. Bathgate, F. Lin, K. Kawamura, and J. D. Wade Analogs of Insulin-like Peptide 3 (INSL3) B-chain Are LGR8 Antagonists in Vitro and in Vivo J. Biol. Chem., May 12, 2006; 281(19): 13068 - 13074. [Abstract] [Full Text] [PDF] |
||||
![]() |
L J Spicer, P Y Aad, D Allen, S Mazerbourg, and A J Hsueh Growth differentiation factor-9 has divergent effects on proliferation and steroidogenesis of bovine granulosa cells. J. Endocrinol., May 1, 2006; 189(2): 329 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization Endocr. Rev., April 1, 2006; 27(2): 170 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
C M Allan, Y Wang, M Jimenez, B Marshan, J Spaliviero, P Illingworth, and D J Handelsman Follicle-stimulating hormone increases primordial follicle reserve in mature female hypogonadal mice. J. Endocrinol., March 1, 2006; 188(3): 549 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A Slot, J. Kastelijn, A. Bachelot, P. A Kelly, N. Binart, and K. J Teerds Reduced recruitment and survival of primordial and growing follicles in GH receptor-deficient mice. Reproduction, March 1, 2006; 131(3): 525 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Guigon and S. Magre Contribution of Germ Cells to the Differentiation and Maturation of the Ovary: Insights from Models of Germ Cell Depletion Biol Reprod, March 1, 2006; 74(3): 450 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A Slot, M. Voorendt, M. de Boer-Brouwer, H. H van Vugt, and K. J Teerds Estrous cycle dependent changes in expression and distribution of Fas, Fas ligand, Bcl-2, Bax, and pro- and active caspase-3 in the rat ovary J. Endocrinol., February 1, 2006; 188(2): 179 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Visser, F. H de Jong, J. S E Laven, and A. P N Themmen Anti-Mullerian hormone: a new marker for ovarian function Reproduction, January 1, 2006; 131(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Navarro, R. Torrejon, M. J. Bandez, J. M. Lopez-Cepero, and A. Boveris Mitochondrial function and mitochondria-induced apoptosis in an overstimulated rat ovarian cycle Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1101 - E1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Y. Ng, O. S. Tang, C. C. W. Chan, and P. C. Ho Ovarian stromal blood flow in the prediction of ovarian response during in vitro fertilization treatment Hum. Reprod., November 1, 2005; 20(11): 3147 - 3151. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Kreeger, N. N. Fernandes, T. K. Woodruff, and L. D. Shea Regulation of Mouse Follicle Development by Follicle-Stimulating Hormone in a Three-Dimensional In Vitro Culture System Is Dependent on Follicle Stage and Dose Biol Reprod, November 1, 2005; 73(5): 942 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Su, J. C. Wu, J. R. Sommer, A. J. Gore, R. M. Petters, and W. L. Miller Conditional Induction of Ovulation in Mice Biol Reprod, October 1, 2005; 73(4): 681 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Skinner Regulation of primordial follicle assembly and development Hum. Reprod. Update, September 1, 2005; 11(5): 461 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Greb, K. Grieshaber, J. Gromoll, B. Sonntag, E. Nieschlag, L. Kiesel, and M. Simoni A Common Single Nucleotide Polymorphism in Exon 10 of the Human Follicle Stimulating Hormone Receptor Is a Major Determinant of Length and Hormonal Dynamics of the Menstrual Cycle J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4866 - 4872. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Y. Ng, C. C. W. Chan, W. S. B. Yeung, and P. C. Ho Comparison of ovarian stromal blood flow between fertile women with normal ovaries and infertile women with polycystic ovary syndrome Hum. Reprod., July 1, 2005; 20(7): 1881 - 1886. [Abstract] [Full Text] [PDF] |
||||
![]() |
ESHRE Capri Workshop Group Fertility and ageing Hum. Reprod. Update, May 1, 2005; 11(3): 261 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Park, E. T. Maizels, Z. J. Feiger, H. Alam, C. A. Peters, T. K. Woodruff, T. G. Unterman, E. J. Lee, J. L. Jameson, and M. Hunzicker-Dunn Induction of Cyclin D2 in Rat Granulosa Cells Requires FSH-dependent Relief from FOXO1 Repression Coupled with Positive Signals from Smad J. Biol. Chem., March 11, 2005; 280(10): 9135 - 9148. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Hussein Apoptosis in the ovary: molecular mechanisms Hum. Reprod. Update, March 1, 2005; 11(2): 162 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. N. Themmen Anti-Mullerian Hormone: Its Role in Follicular Growth Initiation and Survival and as an Ovarian Reserve Marker J Natl Cancer Inst Monographs, March 1, 2005; 2005(34): 18 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Parborell, G. Irusta, A. Vitale, O. Gonzalez, A. Pecci, and M. Tesone Gonadotropin-Releasing Hormone Antagonist Antide Inhibits Apoptosis of Preovulatory Follicle Cells in Rat Ovary Biol Reprod, March 1, 2005; 72(3): 659 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Fraser, H. Wilson, J. S. Rudge, and S. J. Wiegand Single Injections of Vascular Endothelial Growth Factor Trap Block Ovulation in the Macaque and Produce a Prolonged, Dose-Related Suppression of Ovarian Function J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1114 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kaivo-Oja, D. G. Mottershead, S. Mazerbourg, S. Myllymaa, S. Duprat, R. B. Gilchrist, N. P. Groome, A. J. Hsueh, and O. Ritvos Adenoviral Gene Transfer Allows Smad-Responsive Gene Promoter Analyses and Delineation of Type I Receptor Usage of Transforming Growth Factor-{beta} Family Ligands in Cultured Human Granulosa Luteal Cells J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 271 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jonard, P. Pigny, L. Jacquesson, C. Demerle-Roux, Y. Robert, and D. Dewailly The ovarian markers of the FSH insufficiency in functional hypothalamic amenorrhoea Hum. Reprod., January 1, 2005; 20(1): 101 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang, K. M. Whitworth, N. J. Bivens, J. E. Ries, R. J. Woods, L. J. Forrester, G. K. Springer, N. Mathialagan, C. Agca, R. S. Prather, et al. Large-Scale Generation and Analysis of Expressed Sequence Tags from Porcine Ovary Biol Reprod, December 1, 2004; 71(6): 1991 - 2002. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimizu, Y. Miyahayashi, M. Yokoo, Y. Hoshino, H. Sasada, and E. Sato Molecular cloning of porcine growth differentiation factor 9 (GDF-9) cDNA and its role in early folliculogenesis: direct ovarian injection of GDF-9 gene fragments promotes early folliculogenesis Reproduction, November 1, 2004; 128(5): 537 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lenie, R. Cortvrindt, T. Adriaenssens, and J. Smitz A Reproducible Two-Step Culture System for Isolated Primary Mouse Ovarian Follicles as Single Functional Units Biol Reprod, November 1, 2004; 71(5): 1730 - 1738. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Clark, H. F. Irving-Rodgers, A. M. Dharmarajan, and R. J. Rodgers Theca Interna: The Other Side of Bovine Follicular Atresia Biol Reprod, October 1, 2004; 71(4): 1071 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Y. Ng, C. C. W. Chan, W. S. B. Yeung, and P. C. Ho Effect of age on ovarian stromal flow measured by three-dimensional ultrasound with power Doppler in Chinese women with proven fertility Hum. Reprod., September 1, 2004; 19(9): 2132 - 2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang and W. Ge Cloning of Epidermal Growth Factor (EGF) and EGF Receptor from the Zebrafish Ovary: Evidence for EGF as a Potential Paracrine Factor from the Oocyte to Regulate Activin/Follistatin System in the Follicle Cells Biol Reprod, September 1, 2004; 71(3): 749 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Hu, P.-H. Wang, S. Yeh, R.-S. Wang, C. Xie, Q. Xu, X. Zhou, H.-T. Chao, M.-Y. Tsai, and C. Chang Subfertility and defective folliculogenesis in female mice lacking androgen receptor PNAS, August 3, 2004; 101(31): 11209 - 11214. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Luo, K. Kawamura, C. Klein, and A. J. W. Hsueh Paracrine Regulation of Ovarian Granulosa Cell Differentiation by Stanniocalcin (STC) 1: Mediation through Specific STC1 Receptors Mol. Endocrinol., August 1, 2004; 18(8): 2085 - 2096. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Miro, S. W. Parker, L. J. Aspinall, J. Coley, P. W. Perry, and J. E. Ellis Relationship between Follicle-Stimulating Hormone Levels at the Beginning of the Human Menstrual Cycle, Length of the Follicular Phase and Excreted Estrogens: The FREEDOM Study J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3270 - 3275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Cunningham, Q. Zhu, and J. M. Hammond FoxO1a Can Alter Cell Cycle Progression by Regulating the Nuclear Localization of p27kip in Granulosa Cells Mol. Endocrinol., July 1, 2004; 18(7): 1756 - 1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Salvador, M. P. Flynn, J. Avila, S. Reierstad, E. T. Maizels, H. Alam, Y. Park, J. D. Scott, D. W. Carr, and M. Hunzicker-Dunn Neuronal Microtubule-associated Protein 2D Is a Dual A-kinase Anchoring Protein Expressed in Rat Ovarian Granulosa Cells J. Biol. Chem., June 25, 2004; 279(26): 27621 - 27632. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |